Novartis

Ionis, Akcea boosted by a positive PhII for their Novartis castoff cardio drug — and they plan to push ahead into pivotals
Endpoints
Wed, 01/22/20 - 11:00 am
Novartis
Akcea
Medco
AKCEA-APOCIII-LRx
antisense
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Novartis' David Lennon on next steps for AveXis, selling Zolgensma's price to the public
BioPharma Dive
Wed, 01/15/20 - 11:36 pm
Novartis
SMA
AveXis
Zolgensma
drug pricing
Novartis Starts 2020 a Step Ahead of Other Big Pharmas with the Most Newly Approved Drugs
Motley Fool
Wed, 01/15/20 - 11:01 pm
Novartis
FDA
drug approvals
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
AbbVie
Boehringer Ingelheim
Skyrizi
Novartis
Cosentyx
psoriasis
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Wed, 01/15/20 - 10:49 am
Novartis
Pharma CEOs
Vas Narasimhan
drug launches
JPMHC 2020
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
Endpoints
Tue, 01/14/20 - 10:20 am
SMA
Roche
risdiplam
Biogen
Novartis
drug pricing
JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another
Fierce Pharma
Mon, 01/13/20 - 11:55 pm
JPMHC 2020
Teva Pharmaceuticals
Novartis
Gilead Sciences
M&A
Pharma CEOs
JPM: With new ethics plan, Novartis chief puts his money where his mouth is
Fierce Pharma
Mon, 01/13/20 - 11:45 pm
Novartis
ethics
Pharma CEOs
Vas Narasimhan
JPMHC 2020
Aduro's staffers feel the sting, again, after Novartis walks away
Fierce Biotech
Fri, 01/10/20 - 10:35 am
Aduro BioTech
layoffs
Novartis
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
M&A
AbbVie
Allergan
Astellas
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Novartis, Merck and Allergan raise drug prices to start 2020, joining Big Pharma peers
Fierce Pharma
Mon, 01/6/20 - 10:46 am
drug pricing
Merck
Allergan
Novartis
3 Rare Disease Drug Launches to Watch in 2020
Motley Fool
Sat, 01/4/20 - 07:38 pm
Global Blood Therapeutics
sickle cell disease
Oxbryta
Novartis
SCD
Adakveo
Alnylam
Givlaari
acute hepatic porphyria
FDA
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
Four Major Biopharma Scandals in 2019
BioSpace
Thu, 01/2/20 - 10:44 am
scandal
Novartis
Zolgensma
data manipulation
China
CRISPR
IP theft
Purdue Pharma
Sackler family
oxycontin
Is there a future for pharma in neuro?
Fierce Biotech
Sun, 12/22/19 - 12:25 am
Neuroscience
R&D
Eli Lilly
Amgen
GSK
Novartis
Zolgensma for free? Yes, but advocates worry about Novartis' lottery-style giveaway
Fierce Pharma
Thu, 12/19/19 - 12:57 pm
Novartis
Zolgensma
SMA
gene therapy
drug pricing
patients
Novartis elects to keep one heart drug, discard the other from option deal with Akcea, Ionis
Endpoints
Thu, 12/19/19 - 12:51 pm
Novartis
Akcea
Ionis
AKCEA-APO(a)-L
ACEKA-APOCIII-L
Aduro stung as Novartis drops work on STING drug
Fierce Biotech
Wed, 12/18/19 - 10:34 am
Aduro BioTech
Novartis
SEC
ADU-S100
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Pharmaforum
Tue, 12/17/19 - 10:34 am
Novartis
Europe
GSK
Sanofi
AstraZeneca
Roche

Pages